Drug Profile
Leuprorelin depot - Baxter International
Alternative Names: LeuProMaxxLatest Information Update: 18 Nov 2021
Price :
$50
*
At a glance
- Originator
- Developer SICOR; Teva Pharmaceutical Industries
- Class Antineoplastics; Gonadotropins; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Gonadotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Endometriosis; Prostate cancer; Uterine leiomyoma
Most Recent Events
- 02 Feb 2004 Clinical trials in Endometriosis in Europe (Parenteral)
- 02 Feb 2004 Clinical trials in Prostate cancer in Europe (Parenteral)
- 02 Feb 2004 Clinical trials in Uterine leiomyoma in Europe (Parenteral)